In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Lantern Pharma Inc (NASDAQ: LTRN) closed at $3.03 down -0.98% from its previous closing price of $3.06. In other words, the price has decreased by -$0.98 from its previous closing price. On the day, 83640.0 shares were traded. LTRN stock price reached its highest trading level at $3.15 during the session, while it also had its lowest trading level at $2.9567.
Ratios:
For a deeper understanding of Lantern Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.33 and its Current Ratio is at 3.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
. In the most recent recommendation for this company, H.C. Wainwright on October 07, 2021, initiated with a Buy rating and assigned the stock a target price of $32.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’25 when Fletcher Aaron G.L. sold 40,000 shares for $3.09 per share. The transaction valued at 123,600 led to the insider holds 49,957 shares of the business.
Kreis Leslie W. sold 40,000 shares of LTRN for $123,600 on Jun 13 ’25. The 10% Owner now owns 49,957 shares after completing the transaction at $3.09 per share. On Jun 12 ’25, another insider, Fletcher Aaron G.L., who serves as the 10% Owner of the company, sold 60,647 shares for $3.38 each. As a result, the insider received 204,987 and left with 51,860 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LTRN now has a Market Capitalization of 33888800 and an Enterprise Value of 21620180.
Stock Price History:
The Beta on a monthly basis for LTRN is 1.57, which has changed by -0.07272726 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, LTRN has reached a high of $6.12, while it has fallen to a 52-week low of $2.55. The 50-Day Moving Average of the stock is -14.83%, while the 200-Day Moving Average is calculated to be -19.40%.
Shares Statistics:
For the past three months, LTRN has traded an average of 99.10K shares per day and 57150 over the past ten days. A total of 11.04M shares are outstanding, with a floating share count of 8.65M. Insiders hold about 22.68% of the company’s shares, while institutions hold 11.25% stake in the company. Shares short for LTRN as of 1765756800 were 294743 with a Short Ratio of 2.97, compared to 1763078400 on 281028. Therefore, it implies a Short% of Shares Outstanding of 294743 and a Short% of Float of 2.6500002.
Earnings Estimates
The market rating for Lantern Pharma Inc (LTRN) is a result of the insights provided by 1.0 analysts actively involved in the assessment. Analysts are recommending an EPS of between -$1.67 and -$1.67 for the fiscal current year, implying an average EPS of -$1.67. EPS for the following year is -$1.52, with 2.0 analysts recommending between -$1.14 and -$1.91.
